Real-life isoniazid and rifampicin plasma concentrations in children: a tool for therapeutic drug monitoring of tuberculosis

Real-life isoniazid and rifampicin plasma concentrations in children: a tool for therapeutic drug monitoring of tuberculosis

Abstract Background Low plasma levels of first-line antitubercular drugs can be counted among the main causes of poor response to antitubercular therapy, and therapeutic drug monitoring has been proposed as a method to promote tailored treatments for both child and adult patients. The main aim of th...

Full description

Bibliographic Details
Main Authors: Chiara Tersigni, Giulia Boiardi, Lorenzo Tofani, Elisabetta Venturini, Carlotta Montagnani, Barbara Bortone, Leila Bianchi, Elena Chiappini, Maria Iris Cassetta, Stefania Fallani, Andrea Novelli, Luisa Galli
Format: Article
Language:English
Published: BMC 2021-10-01
Series:BMC Infectious Diseases
Subjects:
Therapeutic drug monitoring
Children
Tuberculosis
Treatment compliance
Isoniazid
Rifampicin
Online Access:https://doi.org/10.1186/s12879-021-06764-7

Internet

https://doi.org/10.1186/s12879-021-06764-7

Similar Items